Pharmacogenetics of Breast Cancer - Towards the Individualization of Therapy

Informationen zum Autor Brian Leyland-Jones (Winship Cancer Institute, Emory University, Atlanta, Georgia) (Edited by) Zusammenfassung Pharmacogenetics is becoming increasingly relevant in the diagnosis, treatment, and recovery of cancer patients. A major problem facing oncologists is the outstanding varied efficacy of treatment. Promising advances in pharmacogenetics have allowed the development of effective agents which will enable personalized cancer chemotherapy to become routine for the clinical practice. Inhaltsverzeichnis Pharmacogenomic approaches. Individualized kinetics and dosing. Clasical IHC and FISH state of the art. Affy-based chemo and dosing. Panoply of genomic approaches. Epigenetics. Illumina-based platforms. Proteomics. Measurement of Pharmacodynamic endpoints. What tissues are needed + specimen collection

Product details

• Authors: Brian Leyland-Jones, Brian (Winship Cancer Institute Leyland-Jones
• Assisted by: Brian Leyland-Jones (Editor), Brian (Winship Cancer Institute Leyland-Jones (Editor), Leyland-Jones Brian (Editor)
• Publisher: Taylor & Francis Ltd.
• Languages: English
• Product format: Hardback
• Released: 19.05.2008
• EAN: 9781420052930
• ISBN: 978-1-4200-5293-0
• No. of pages: 350
• Series: Translational Medicine; Translational Medicine
• Subjects: Natural sciences, medicine, IT, technology > Medicine > Clinical medicine; Medicine: general issues, MEDICAL / General, MEDICAL / Gynecology & Obstetrics, MEDICAL / Genetics, MEDICAL / Chemotherapy, Oncology, Gynaecology and obstetrics, Gynaecology & obstetrics, Medical Genetics, MEDICAL / Oncology / Breast Cancer, MEDICAL / Oncology / General